Escherichia coli

Background

Clinical Features

Differential Diagnosis

Acute diarrhea

Infectious

Noninfectious

Watery Diarrhea

Traveler's Diarrhea

Evaluation

  • Stool culture
  • Rapid assay for Shiga toxin

Management of EHEC[2]

  • Supportive only
  • Do not treat with antibiotics (typically the same for ETEC)
    • Antibiotics do not alleviate symptoms, reduce carrier risk of organism, or reduce HUS risk
    • Ciprofloxacin may increase enterotoxin release
  • 7-14 days after infection, highest risk for HUS, which may need follow up and monitoring of:

Antibiotic Sensitivities[3]

Category Antibiotic Sensitivity
PenicillinsPenicillin GR
Penicillin VR
Anti-Staphylocccal PenicillinsMethicillinR
Nafcillin/OxacillinR
Cloxacillin/Diclox.R
Amino-PenicillinsAMP/AmoxI
Amox-ClavS
AMP-SulbS
Anti-Pseudomonal PenicillinsTicarcillinI
Ticar-ClavS
Pip-TazoS
PiperacillinS
CarbapenemsDoripenemS
ErtapenemS
ImipenemS
MeropenemS
AztreonamS
FluroquinolonesCiprofloxacinS
OfloxacinS
PefloxacinS
LevofloxacinS
MoxifloxacinS
GemifloxacinS
GatifloxacinS
1st G CephaloCefazolinS
2nd G. CephaloCefotetanS
CefoxitinS
CefuroximeS
3rd/4th G. CephaloCefotaximeS
CefizoximeS
CefTRIAXoneS
CeftarolineS
CefTAZidimeS
CefepimeS
Oral 1st G. CephaloCefadroxilS
CephalexinS
Oral 2nd G. CephaloCefaclor/LoracarbefS
CefproxilS
Cefuroxime axetilS
Oral 3rd G. CephaloCefiximeS
CeftibutenS
Cefpodox/Cefdinir/CefditorenS
AminoglycosidesGentamicinS
TobramycinS
AmikacinS
ChloramphenicolS
ClindamycinR
MacrolidesErythromycinR
AzithromycinR
ClarithromycinR
KetolideTelithromycinR
TetracyclinesDoxycyclineS
MinocyclineS
GlycylcyclineTigecyclineS
DaptomycinR
Glyco/LipoclycopeptidesVancomycinR
TeicoplaninR
TelavancinR
Fusidic AcidR
TrimethoprimS
TMP-SMXI
Urinary AgentsNitrofurantoinS
FosfomycinS
OtherRifampinR
MetronidazoleR
Quinupristin dalfoppristinR
LinezolidR
ColistimethateS

Key

  • S susceptible/sensitive (usually)
  • I intermediate (variably susceptible/resistant)
  • R resistant (or not effective clinically)
  • S+ synergistic with cell wall antibiotics
  • U sensitive for UTI only (non systemic infection)
  • X1 no data
  • X2 active in vitro, but not used clinically
  • X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
  • X4 active in vitro, but not clinically effective for strep pneumonia

Table Overview

See Also

References

  1. Marx et al. “Cholera and Gastroenteritis caused by Noncholera Vibrio Species”. Rosen’s Emergency Medicine 8th edition vol 1 pg 1245-1246.
  2. Bush LM and Perez MT. Infection by Escherichia coli O157:H7 and Other Enterohemorrhagic E. coli (EHEC). Merck Manual. http://www.merckmanuals.com/professional/infectious-diseases/gram-negative-bacilli/infection-by-escherichia-coli-o157,-c-,h7-and-other-enterohemorrhagic-e,-d-,-coli-(ehec)
  3. Sanford Guide to Antimicrobial Therapy 2014
This article is issued from Wikem. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.